List of bibliographic references
Number of relevant bibliographic references: 22.
[0-20] [
0 - 20][
0 - 22][
20-21][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000329 (2000) |
S A Treseder [Royaume-Uni] ; L A Smith ; P. Jenner | Endogenous dopaminergic tone and dopamine agonist action. |
| 000538 (2001) |
E C Maratos [Royaume-Uni] ; M J Jackson ; R K Pearce ; P. Jenner | Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naïve MPTP-lesioned common marmosets (Callithrix jacchus). |
| 001460 (1992) |
F. Stocchi [Italie] ; S. Ruggieri ; A. Carta ; J. Ryatt ; N. Quinn ; P. Jenner ; C D Marsden ; A. Agnoli | Intravenous boluses and continuous infusions of L-dopa methyl ester in fluctuating patients with Parkinson's disease. |
| 002840 (1990) |
A H Schapira [Royaume-Uni] ; I J Holt ; M. Sweeney ; A E Harding ; P. Jenner ; C D Marsden | Mitochondrial DNA analysis in Parkinson's disease. |
| 004032 (1989) |
W R Gibb [Royaume-Uni] ; M. Terruli ; A J Lees ; P. Jenner ; C D Marsden | The evolution and distribution of morphological changes in the nervous system of the common marmoset following the acute administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. |
| 004534 (1989) |
D T Dexter [Royaume-Uni] ; P. Jenner ; C D Marsden | Oxyferriscorbone elevates the total iron content of blood but not brain. |
| 004562 (1987) |
M. Nomoto [Royaume-Uni] ; S. Stahl ; P. Jenner ; C D Marsden | Antiparkinsonian activity of (+)-PHNO in the MPTP-treated common marmoset. |
| 004594 (1986) |
J. Garvey [Royaume-Uni] ; M. Petersen ; C M Waters ; S P Rose ; S. Hunt ; R. Briggs ; P. Jenner ; C D Marsden | Administration of MPTP to the common marmoset does not alter cortical cholinergic function. |
| 004616 (1988) |
S. Rose [Royaume-Uni] ; P. Jenner ; C D Marsden | The effect of carbidopa on plasma and muscle levels of L-dopa, dopamine, and their metabolites following L-dopa administration to rats. |
| 004646 (1986) |
M L De Ceballos [Royaume-Uni] ; M. Baker ; S. Rose ; P. Jenner ; C D Marsden | Do enkephalins in basal ganglia mediate a physiological motor rest mechanism? |
| 004870 (1993) |
S B Blunt [Royaume-Uni] ; P. Jenner ; C D Marsden | Suppressive effect of L-dopa on dopamine cells remaining in the ventral tegmental area of rats previously exposed to the neurotoxin 6-hydroxydopamine. |
| 004901 (1994) |
D T Dexter [Royaume-Uni] ; A E Holley ; W D Flitter ; T F Slater ; F R Wells ; S E Daniel ; A J Lees ; P. Jenner ; C D Marsden | Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study. |
| 004908 (1994) |
S. Rose [Royaume-Uni] ; P. Jenner ; C D Marsden | Chronic administration does not alter the accumulation of L-dopa into muscle. |
| 004A71 (1996) |
L. Smith [Royaume-Uni] ; M. De Salvia ; P. Jenner ; C D Marsden | An appraisal of the antiparkinsonian activity of piribedil in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets. |
| 004B19 (1995) |
R K Pearce [Royaume-Uni] ; M. Jackson ; L. Smith ; P. Jenner ; C D Marsden | Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix Jacchus). |
| 004B41 (1996) |
B Y Zeng [Royaume-Uni] ; P. Jenner ; C D Marsden | Partial reversal of increased preproenkephalin messenger ribonucleic acid (mRNA) and decreased preprotachykinin mRNA by foetal dopamine cells in unilateral 6-hydroxydopamine-lesioned rat striatum parallels functional recovery. |
| 004B96 (1996) |
G K Wenning [Royaume-Uni] ; R. Granata ; P M Laboyrie ; N P Quinn ; P. Jenner ; C D Marsden | Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration. |
| 004C91 (1997) |
M. Gerlach ; K. Double ; P. Riederer ; E. Hirsch ; K. Jellinger ; P. Jenner ; A. Trautwein ; M B Youdim | Iron in the Parkinsonian substantia nigra. |
| 004E22 (1997) |
L A Smith [Royaume-Uni] ; A. Gordin ; P. Jenner ; C D Marsden | Entacapone enhances levodopa-induced reversal of motor disability in MPTP-treated common marmosets. |
| 004F03 (1998) |
A G Riedl [Royaume-Uni] ; P M Watts ; P. Jenner ; C D Marsden | P450 enzymes and Parkinson's disease: the story so far. |
| 004F06 (1998) |
R K Pearce [Royaume-Uni] ; T. Banerji ; P. Jenner ; C D Marsden | De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "P. Jenner"
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i \
-Sk "P. Jenner" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Ncbi
|étape= Checkpoint
|type= indexItem
|index= Author.i
|clé= P. Jenner
}}
| This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 |  |
